JULIANNE TOMAC
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family O FALLON, IL NPI 1245018944
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family IL Janssen Biotech, Inc. All categories
General Payments — all program years on this page
$1,462.66
- Category: General Payments
- Program years: PY2023–2024
- Record count: 73
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,325.82 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,325.82 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $268.44 | 14 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $141.79 | 8 |
| Incyte Corporation | $105.07 | 6 |
| Daiichi Sankyo Inc. | $94.67 | 4 |
| Regeneron Healthcare Solutions, Inc. | $71.02 | 3 |
| Celgene Corporation | $64.71 | 4 |
| SOBI, INC | $64.19 | 3 |
| JAZZ PHARMACEUTICALS INC. | $63.01 | 2 |
| ABBVIE INC. | $48.06 | 2 |
| Merck Sharp & Dohme Corporation | $47.39 | 3 |
| PFIZER INC. | $43.93 | 2 |
| Tempus AI, Inc | $40.54 | 2 |
| Acerta Pharma LLC | $33.82 | 2 |
| Genentech USA, Inc. | $31.67 | 1 |
| Genmab U.S., Inc. | $27.51 | 1 |
| ADC Therapeutics America, Inc. | $24.38 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.14 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $19.20 | 1 |
| MorphoSys, US Inc. | $18.80 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.17 | 1 |
| BeiGene USA, Inc. | $18.14 | 1 |
| TAIHO ONCOLOGY, INC. | $16.64 | 1 |
| Mirati Therapeutics, Inc. | $15.04 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.85 | 1 |
| PharmaEssentia USA Corporation | $13.64 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.